|
ZNF226 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.50770000040268E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.935100E-03 |
| Normal-vs-Stage2 |
9.957500E-02 |
| Normal-vs-Stage3 |
4.27013979731328E-12 |
| Normal-vs-Stage4 |
7.86150000653407E-09 |
| Stage1-vs-Stage2 |
9.320000E-01 |
| Stage1-vs-Stage3 |
1.62530999999744E-05 |
| Stage1-vs-Stage4 |
2.764000E-04 |
| Stage2-vs-Stage3 |
1.250230E-02 |
| Stage2-vs-Stage4 |
1.173750E-02 |
| Stage3-vs-Stage4 |
8.683200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.99840000103535E-08 |
| Normal-vs-AfricanAmerican |
4.886800E-01 |
| Normal-vs-Asian |
5.148600E-01 |
| Caucasian-vs-AfricanAmerican |
1.712320E-02 |
| Caucasian-vs-Asian |
3.769200E-01 |
| AfricanAmerican-vs-Asian |
9.463000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.53909999967006E-07 |
| Normal-vs-Female |
2.208500E-04 |
| Male-vs-Female |
1.705040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.119240E-03 |
| Normal-vs-Age(41-60Yrs) |
3.47670000000466E-06 |
| Normal-vs-Age(61-80Yrs) |
2.27999999999895E-05 |
| Normal-vs-Age(81-100Yrs) |
7.359600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.810600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.192000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.397200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.721800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.317800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.547000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.771800E-01 |
| Normal-vs-Grade 2 |
9.537400E-03 |
| Normal-vs-Grade 3 |
6.30320018402131E-10 |
| Normal-vs-Grade 4 |
2.55990006969853E-10 |
| Grade 1-vs-Grade 2 |
4.854400E-01 |
| Grade 1-vs-Grade 3 |
3.112500E-02 |
| Grade 1-vs-Grade 4 |
4.179200E-03 |
| Grade 2-vs-Grade 3 |
1.458050E-03 |
| Grade 2-vs-Grade 4 |
2.28740000000061E-05 |
| Grade 3-vs-Grade 4 |
5.186000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.49599999998973E-06 |
| Normal-vs-ccB subtype |
3.301900E-03 |
| ccA subtype-vs-ccB subtype |
7.590600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.002100E-04 |
| Normal-vs-N1 |
1.15990000004729E-06 |
| N0-vs-N1 |
4.084000E-02 |
|
|
